Patents/Inventors

Chengfei Pu

ShanghaiCN16 patents

17 Patents

US122972672025
Humanized Anti-cd19 Antibody and Use Thereof with Chimeric Antigen Receptor
Innovative Cellular Therapeutics Holdings, Ltd.
0 cites
US122409152025
Chimeric Antigen Receptor Cells for Treating Solid Tumor
Innovative Cellular Therapeutics, Inc.
0 cites
US121509602024
Modified Cell Expansion and Uses Thereof
Innovative Cellular Therapeutics, Inc.
0 cites
US120763432024
Engineered Safety in Cell Therapy
Innovative Cellular Therapeutics, Inc.
0 cites
US120436542024
Anti-gcc Antibody and CAR Thereof for Treating Digestive System Cancer
Innovative Cellular Therapeutics, Inc.
0 cites
US119819202024
Modified Cell with Enhanced Migration Capability
Innovative Cellular Therapeutics Holdings, Ltd.
0 cites
US119327002024
Use of Chimeric Antigen Receptor Modified Cells to Treat Cancer
Innovative Cellular Therapeutics Holdings, Ltd.
0 cites
US118664942024
CAR T Therapy Through Uses of Co-stimulation
Innovative Cellular Therapeutics Holdings, Ltd.
0 cites
US118589772024
Modified TCR and Uses Thereof
Innovative Cellular Therapeutics, Inc.
0 cites
US118331742023
Modified Cell with Enhanced Functionality and Cellular Therapy Thereof
Innovative Cellular Therapeutics, Inc.
0 cites
US118345022023
Reducing Immune Inhibition Induced by SIGLEC-15
Innovative Cellular Therapeutics Holdings, Ltd.
0 cites
US117880722023
Activation of APC in Immunotherapy
Innovative Cellular Therapeutics Holdings, Ltd.
0 cites
US117391362023
Inducible Dominant Negative PD-1 and Uses in Adoptive Cell Therapy
Innovative Cellular Therapeutics Holdings, Ltd.
0 cites
US117013852023
Modulation of Cell Function for Immunotherapy
Innovative Cellular Therapeutics Holdings, Ltd.
0 cites
US116908742023
Use of Chimeric Antigen Receptor Modified Cells to Treat Autoimmune Disease
Zhejiang University
0 cites
US116334272023
Vaccine and Uses Thereof in Cell Therapy
Innovative Cellular Therapeutics, Inc.
0 cites
US115662232023
Chimeric Antigen Receptor Cell Preparation and Uses Thereof
Innovative Cellular Therapeutics Holdings, Ltd.
0 cites